For the quarter ending 2025-09-30, GOCO had -$3,514K decrease in cash & cash equivalents over the period. -$35,022K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | -313,918 | -125,775 |
| Intangible asset impairment charges | - | 53,000 |
| Share-based compensation | 3,496 | 2,668 |
| Depreciation and amortization | 3,508 | 5,646 |
| Amortization of intangible assets | 23,514 | 47,028 |
| Amortization of debt discount and issuance costs | 2,695 | 1,992 |
| Deferred tax liability | 0 | 403 |
| Non-cash lease expense | 749 | 1,710 |
| Other non-cash items | 21 | 325 |
| Accrued interest payable in kind | 13,514 | 13,808 |
| Loss on extinguishment of debt | -1,655 | - |
| Indefinite and long-lived asset impairment charges | 259,961 | - |
| Gain on bargain purchase | 0 | - |
| Accounts receivable | -141 | -4,309 |
| Operating lease impairment charges | - | 798 |
| Commissions receivable | -32,604 | -56,994 |
| Prepaid expenses and other assets | -10,292 | -8,035 |
| Accounts payable | -8,035 | 5,296 |
| Accrued liabilities | -54 | -60,329 |
| Deferred revenue | -4,246 | -20,280 |
| Commissions payable | -3,559 | -38,732 |
| Operating lease liabilities | -1,172 | -2,702 |
| Other liabilities | 23 | -3,766 |
| Net cash provided by (used in) operating activities | -32,651 | -50,222 |
| Acquisition of business, net | 0 | - |
| Purchases of property, equipment and software | 2,371 | 5,877 |
| Net cash provided by (used in) investing activities | -2,371 | -5,877 |
| Repayment of borrowings | 0 | 2,375 |
| Proceeds from borrowings | 39,499 | 58,500 |
| Debt issuance cost payments | 7,977 | 431 |
| Repurchase of shares to satisfy employee tax withholding obligations | 102 | 5,028 |
| Proceeds from stock option exercises | 0 | 1 |
| Net cash provided by (used in) financing activities | 31,420 | 50,667 |
| Effect of exchange rate changes on cash and cash equivalents | 88 | 101 |
| Increase (decrease) in cash and cash equivalents | -3,514 | -5,331 |
| Cash and cash equivalents at beginning of period | 40,921 | - |
| Cash and cash equivalents at end of period | 32,076 | - |
GoHealth, Inc. (GOCO)
GoHealth, Inc. (GOCO)